DALLAS (May 31, 2022)—Enhabit Home Health & Hospice, a home health and hospice care provider, announced it filed a Form 10 registration statement with the Securities and Exchange Commission (SEC) on May 25, 2022, in connection with its spin-off from Encompass Health Corporation. The spin-off is anticipated to occur on July 1, 2022, subject to various conditions. Upon completion of the spin-off, Enhabit will become an independent, publicly traded company.
While the Enhabit name is new, the company has a long track record of success and deep expertise in the home health and hospice industries. Enhabit is one of the largest home health providers in the nation, with a vast geographic footprint and an extensive team of clinicians delivering the highest quality of care to all patients, at their homes and on their terms.
In addition, Enhabit announced anticipated appointees to its board of directors at the time of the spin-off, including Enhabit President and CEO Barbara Jacobsmeyer and eight other professionals from across the health care, technology and financial sectors, who qualify as "independent" under the New York Stock Exchange corporate governance standards. Five of the board members previously served on Encompass Health's board of directors. Service by the legacy Encompass Health directors on a transitional basis will facilitate a smooth start for Enhabit as a public company, particularly given their knowledge of the business. The board is committed to an orderly and gradual transition of the five legacy Encompass Health board members over the next two years and is actively engaged in recruiting additional candidates.
The members of Enhabit's board of directors will include:
- Leo I. Higdon Jr., who will serve as chairman of the board
- Barbara A. Jacobsmeyer, president and CEO of Enhabit
- Jeffrey W. Bolton
- Yvonne M. Curl
- Charles M. Elson
- Erin P. Hoeflinger
- John E. Maupin Jr.
- Gregory S. Rush
- L. Edward Shaw Jr.
"This announcement is another exciting step as Enhabit embarks on our next chapter as an independent, public company," Jacobsmeyer said. "We have a comprehensive transition plan in place and are confident that the board's diverse background and experience will help guide us into the future as we work to expand what's possible for patient care at home."
